Related Experiment Video
Updated: Jun 13, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses
Yu-Ru Lee1, Wei-Chien Yuan, Hsuan-Chung Ho
1Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
Abstract:
Death-associated protein kinase (DAPK) was identified as a mediator of interferon (IFN)-induced cell death. How IFN controls DAPK activation remains largely unknown. Here, we identify the BTB-Kelch protein KLHL20 as a negative regulator of DAPK. KLHL20 binds DAPK and Cullin 3 (Cul3) via its Kelch-repeat domain and BTB domain, respectively. The KLHL20-Cul3-ROC1 E3 ligase complex promotes DAPK polyubiquitination, thereby inducing the proteasomal degradation of DAPK. Accordingly, depletion of KLHL20 diminishes DAPK ubiquitination and degradation. The KLHL20-mediated DAPK ubiquitination is suppressed in cells receiving IFN-alpha or IFN-gamma, which induces an enrichment/sequestration of KLHL20 in the PML nuclear bodies, thereby separating KLHL20 from DAPK. Consequently, IFN triggers the stabilization of DAPK. This mechanism of DAPK stabilization is crucial for determining IFN responsiveness of tumor cells and contributes to IFN-induced autophagy. This study identifies KLHL20-Cul3-ROC1 as an E3 ligase for DAPK ubiquitination and reveals a regulatory mechanism of DAPK, through blocking its accessibility to this E3 ligase, in IFN-induced apoptotic and autophagic death. Our findings may be relevant to the problem of IFN resistance in cancer therapy.
Insights
The BTB-Kelch protein KLHL20 targets death-associated protein kinase (DAPK) for degradation. Interferon (IFN) blocks this, stabilizing DAPK and enhancing cancer cell death, potentially overcoming IFN resistance.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- Death-associated protein kinase (DAPK) mediates interferon (IFN)-induced cell death.
- The precise mechanisms by which IFN regulates DAPK activation are not fully understood.
- Understanding DAPK regulation is crucial for cancer therapy involving IFNs.
Purpose of the Study:
- To identify novel regulators of DAPK.
- To elucidate the mechanism of DAPK regulation by interferons.
- To explore the role of DAPK stabilization in IFN responsiveness and cancer therapy.
Main Methods:
- Identification of KLHL20 as a DAPK-binding protein.
- Characterization of the KLHL20-Cullin 3 (Cul3)-ROC1 E3 ligase complex.
- Analysis of DAPK ubiquitination, degradation, and stabilization in response to IFN.
Main Results:
- KLHL20 targets DAPK for polyubiquitination and proteasomal degradation via the KLHL20-Cul3-ROC1 E3 ligase complex.
- IFN treatment causes KLHL20 to sequester in PML nuclear bodies, separating it from DAPK.
- IFN-induced sequestration of KLHL20 leads to DAPK stabilization, enhancing IFN responsiveness and promoting cell death.
Conclusions:
- KLHL20 acts as a negative regulator of DAPK by promoting its degradation.
- IFN-induced sequestration of KLHL20 is a key mechanism for DAPK stabilization.
- This pathway is critical for IFN-induced apoptosis and autophagy, offering potential strategies to overcome IFN resistance in cancer.
Related Concept Videos
Anaphase Promoting Complex
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulation of the Unfolded Protein Response
The Unfolded Protein Response
Inhibition of Cdk Activity

